Advertisement
U.S. markets close in 38 minutes
Advertisement

Viking Therapeutics Inc (1VT.DU)

Dusseldorf - Dusseldorf Delayed Price. Currency in EUR
16.59+0.52 (+3.23%)
As of 07:30PM CET. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
Operating Expense
91,825
70,355
55,682
42,662
32,687
Operating Income
-91,825
-70,355
-55,682
-42,662
-32,687
Net Non Operating Interest Income Expense
10,976
1,530
685
3,127
6,904
Other Income Expense
-
-42
7
40
4
Pretax Income
-80,849
-68,867
-54,990
-39,495
-25,779
Net Income Common Stockholders
-80,849
-68,867
-54,990
-39,495
-25,779
Diluted NI Available to Com Stockholders
-80,849
-68,867
-54,990
-39,495
-25,779
Basic EPS
-0.92
-0.90
-0.71
-0.54
-0.36
Diluted EPS
-0.92
-0.90
-0.71
-0.54
-0.36
Basic Average Shares
88,507
76,834
77,198
72,597
71,959
Diluted Average Shares
88,507
76,834
77,198
72,597
71,959
Total Operating Income as Reported
-91,825
-70,355
-55,682
-42,662
-32,687
Total Expenses
91,825
70,355
55,682
42,662
32,687
Net Income from Continuing & Discontinued Operation
-80,849
-68,867
-54,990
-39,495
-25,779
Normalized Income
-80,849
-68,825
-54,997
-39,535
-25,783
Interest Income
11,046
1,589
703
3,233
7,050
Interest Expense
-
-
-
-
0
Net Interest Income
10,976
1,530
685
3,127
6,904
EBIT
-91,825
-70,355
-55,682
-42,662
-25,779
EBITDA
-91,535
-70,355
-55,682
-42,662
-25,519
Reconciled Depreciation
290
291
296
277
260
Net Income from Continuing Operation Net Minority Interest
-80,849
-68,867
-54,990
-39,495
-25,779
Total Unusual Items Excluding Goodwill
0
-42
7
40
4
Total Unusual Items
0
-42
7
40
4
Normalized EBITDA
-91,535
-70,313
-55,689
-42,702
-25,523
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0